NEON THERAPEUTICS, INC. Operating Expenses
NEON THERAPEUTICS, INC. reported Operating Expenses of $16.67 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2020-05-01
- NEON THERAPEUTICS, INC. operating expenses for the quarter ending 2020-03-31 was $16.67M, a 22.77% decline year-over-year.
- NEON THERAPEUTICS, INC. operating expenses for the quarter ending 2019-12-31 was $17.99M, a 24.33% decline year-over-year.
- NEON THERAPEUTICS, INC. operating expenses for the quarter ending 2019-09-30 was $19.25M, a 1.05% increase year-over-year.
- NEON THERAPEUTICS, INC. operating expenses for the quarter ending 2019-06-30 was $22.32M, a 16.73% increase year-over-year.
- NEON THERAPEUTICS, INC. operating expenses for fiscal 2019 was $81.14M, a 3.10% increase from fiscal 2018.
- NEON THERAPEUTICS, INC. operating expenses for fiscal 2018 was $78.70M, a 63.66% increase from fiscal 2017.
- NEON THERAPEUTICS, INC. operating expenses for fiscal 2017 was $48.09M, a 75.36% increase from fiscal 2016.
- NEON THERAPEUTICS, INC. operating expenses for fiscal 2016 was $27.42M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2020-03-31 | $16.67M 10-Q · filed 2020-05-01 | $34.66M derived: sum of 2 quarters · filed 2020-05-01 | $53.91M derived: sum of 3 quarters · filed 2020-05-01 | $76.22M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-12-31 | $17.99M 10-K · filed 2020-03-02 | $37.24M derived: sum of 2 quarters · filed 2020-03-02 | $59.56M derived: sum of 3 quarters · filed 2020-03-02 | $81.14M 10-K · filed 2020-03-02 |
| 2019-09-30 | $19.25M 10-K · filed 2020-03-02 | $41.57M derived: sum of 2 quarters · filed 2020-03-02 | $63.15M 10-Q · filed 2019-11-12 | $86.92M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-06-30 | $22.32M 10-K · filed 2020-03-02 | $43.90M 10-Q · filed 2019-08-06 | $67.67M derived: sum of 3 quarters · filed 2020-05-01 | $86.72M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-03-31 | $21.58M 10-Q · filed 2020-05-01 | $45.35M derived: sum of 2 quarters · filed 2020-05-01 | $64.41M derived: sum of 3 quarters · filed 2020-05-01 | $83.52M derived: sum of 4 quarters · filed 2020-05-01 |
| 2018-12-31 | $23.77M 10-K · filed 2020-03-02 | $42.83M derived: sum of 2 quarters · filed 2020-03-02 | $61.94M derived: sum of 3 quarters · filed 2020-03-02 | $78.70M 10-K · filed 2020-03-02 |
| 2018-09-30 | $19.05M 10-K · filed 2020-03-02 | $38.17M derived: sum of 2 quarters · filed 2020-03-02 | $54.93M 10-Q · filed 2019-11-12 | $69.56M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $19.12M 10-K · filed 2020-03-02 | $35.87M 10-Q · filed 2019-08-06 | $50.51M derived: sum of 3 quarters · filed 2020-03-02 | $64.65M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $16.76M 10-K · filed 2020-03-02 | $31.39M derived: sum of 2 quarters · filed 2020-03-02 | $45.53M derived: sum of 3 quarters · filed 2020-03-02 | $55.30M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $14.63M 10-K · filed 2019-03-11 | $28.77M derived: sum of 2 quarters · filed 2019-03-11 | $38.54M derived: sum of 3 quarters · filed 2019-03-11 | $48.09M 10-K · filed 2019-03-11 |
| 2017-09-30 | $14.14M 10-K · filed 2019-03-11 | $23.91M derived: sum of 2 quarters · filed 2019-03-11 | $33.45M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $9.76M 10-K · filed 2019-03-11 | $19.31M 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | $9.55M 10-K · filed 2019-03-11 | |||
| 2016-12-31 | $27.42M 10-K · filed 2019-03-11 |